Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ampio Pharmaceuticals Inc | AMPE | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.62 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.62 | 0.62 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.62 - 8.298 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.62 | USD |
Ampio Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 241.29k | 832.02k | - | 0 | -8.63M | -10.37 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ampio Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AMPE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.8896 | 0.9088 | 0.62 | 0.7095074 | 36,198 | -0.2696 | -30.31% |
| 1 Month | 1.63 | 1.99 | 0.62 | 1.07 | 76,353 | -1.01 | -61.96% |
| 3 Months | 1.65 | 2.47 | 0.62 | 1.62 | 72,130 | -1.03 | -62.42% |
| 6 Months | 3.51 | 7.47 | 0.62 | 4.11 | 284,584 | -2.89 | -82.34% |
| 1 Year | 4.028 | 8.298 | 0.62 | 4.50 | 348,441 | -3.41 | -84.61% |
| 3 Years | 468.00 | 601.50 | 0.62 | 143.59 | 1,761,004 | -467.38 | -99.87% |
| 5 Years | 156.00 | 894.00 | 0.62 | 245.27 | 2,037,270 | -155.38 | -99.60% |
Ampio Pharmaceuticals Description
| Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunomodulatory therapies for the treatment of pain from osteoarthritis. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19 induced respiratory distress. |
